Unknown

Dataset Information

0

Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein.


ABSTRACT: Trypanosoma cruzi trypomastigotes are exquisitely resistant to the lytic effects of vertebrate complement, and this characteristic contributes to the survival of the parasites in the host bloodstream. Trypomastigotes avoid complement-mediated lysis by the production of a surface glycoprotein that inhibits the formation of the alternative and classical C3 convertase, thus preventing activation and amplification of the complement cascade at the parasite surface. We have developed a monoclonal antibody to the 160-kDa T. cruzi complement regulatory protein (CRP) and describe a one-step immunoaffinity purification procedure. The CRP was purified to homogeneity and subjected to amino-terminal peptide sequence analysis. Based on the protein sequence obtained, the CRP was identified as a member of a large family of trypomastigote-specific genes, and a complete cDNA was isolated and sequenced. The complete coding sequence was cloned in Escherichia coli, and antibodies raised against the full-length recombinant protein reacted specifically with a 160-kDa protein in trypomastigote membrane protein preparations as well as with native, purified CRP. Indirect immunofluorescence revealed that the protein is uniformly expressed at the cell surfaces of trypomastigotes.

SUBMITTER: Norris KA 

PROVIDER: S-EPMC174602 | biostudies-other | 1997 Feb

REPOSITORIES: biostudies-other

altmetric image

Publications

Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein.

Norris K A KA   Schrimpf J E JE   Szabo M J MJ  

Infection and immunity 19970201 2


Trypanosoma cruzi trypomastigotes are exquisitely resistant to the lytic effects of vertebrate complement, and this characteristic contributes to the survival of the parasites in the host bloodstream. Trypomastigotes avoid complement-mediated lysis by the production of a surface glycoprotein that inhibits the formation of the alternative and classical C3 convertase, thus preventing activation and amplification of the complement cascade at the parasite surface. We have developed a monoclonal anti  ...[more]

Similar Datasets

| S-EPMC2223453 | biostudies-literature
| S-EPMC4281920 | biostudies-literature
| S-EPMC2191125 | biostudies-other
| S-EPMC1074381 | biostudies-literature
| S-EPMC2798230 | biostudies-literature
| S-EPMC3060929 | biostudies-literature
| S-EPMC6456187 | biostudies-literature
2023-04-11 | GSE229354 | GEO
| S-EPMC281144 | biostudies-other
| S-EPMC4660618 | biostudies-literature